Crawley Caecilie, Savino Nadia, Halby Cecilie, Sander Stine Dydensborg, Andersen Anne-Marie Nybo, Arumugam Manimozhiyan, Murray Joseph, Christensen Robin, Husby Steffen
Hans Christian Andersen Children's Hospital, Odense University Hospital, Odense, Denmark.
Department of Clinical Research, University of Southern Denmark, Odense, Denmark.
Aliment Pharmacol Ther. 2022 May;55(9):1116-1127. doi: 10.1111/apt.16914. Epub 2022 Mar 29.
The popularity of the gluten-free diet and sales of gluten-free products have increased immensely.
To investigate whether gluten induces gastrointestinal symptoms, measured by self-reported questionnaires, as well as mental health symptoms in adolescents from a population-based cohort.
The eligible participants (n = 273) were recruited from a population-based cohort of 1266 adolescents and had at least four different gastrointestinal symptoms. Phase one (n = 54) was a run-in phase where the participants lived gluten-free for 2 weeks. If they improved they continued to phase 2 (n = 33), a blinded randomised cross-over trial. Participants were blindly randomised either to start with 7 days of gluten, eating two granola bars containing 10 g of gluten or to 7 days on placebo, eating two granola bars without gluten, followed by the reverse and separated by a 7-day washout period. The effects of the intervention on gastrointestinal symptoms and mental health symptoms were assessed.
In total, 54/273 participants entered the run-in phase and 35 were eligible for randomization. A total of 33 were randomised and 32 completed the trial. The median age was 20.3 (IQR 19.2-20.9) and 32/33 participants were females. Compared with a placebo, gluten did not induce gastrointestinal symptoms. The difference in the average VAS was -0.01 (95% confidence interval -2.07 to 2.05). Nor did we find a difference in the outcomes measuring mental health.
Compared with placebo, adding gluten to the diet did not induce gastrointestinal symptoms or worsened mental health in adolescents recruited from a population-based cohort. The trial registration number is NCT04639921.
无麸质饮食的流行程度以及无麸质产品的销量大幅增加。
通过自我报告问卷来调查麸质是否会引发胃肠道症状以及基于人群队列的青少年的心理健康症状。
符合条件的参与者(n = 273)从一个包含1266名青少年的人群队列中招募,且至少有四种不同的胃肠道症状。第一阶段(n = 54)为适应期,参与者进行为期2周的无麸质饮食。如果症状有所改善,他们将进入第二阶段(n = 33),即一项双盲随机交叉试验。参与者被随机分为两组,一组开始食用7天含有10克麸质的格兰诺拉燕麦棒,另一组开始食用7天不含麸质的格兰诺拉燕麦棒作为安慰剂,之后两组互换,中间有7天的洗脱期。评估干预措施对胃肠道症状和心理健康症状的影响。
共有54/273名参与者进入适应期,35名符合随机分组条件。总共33名参与者被随机分组,32名完成了试验。中位年龄为20.3岁(四分位间距19.2 - 20.9),32/33名参与者为女性。与安慰剂相比,麸质并未引发胃肠道症状。平均视觉模拟评分的差异为-0.01(95%置信区间为-2.07至2.05)。我们在心理健康测量结果方面也未发现差异。
与安慰剂相比,在从人群队列中招募的青少年饮食中添加麸质不会引发胃肠道症状或使心理健康恶化。试验注册号为NCT04639921。